FDA granted MiMedx permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis. Enrollment of 158 patients will begin in 4Q17.
The prospective, double blinded, randomized controlled trial will compare the Micronized dehydrated Human Amnion Chorion Membrane (dHACM) injection to saline placebo.
FDA granted MiMedx permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis. Enrollment of 158 patients will begin in 4Q17.
The prospective, double blinded, randomized controlled trial will compare the Micronized dehydrated Human Amnion Chorion...
FDA granted MiMedx permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis. Enrollment of 158 patients will begin in 4Q17.
The prospective, double blinded, randomized controlled trial will compare the Micronized dehydrated Human Amnion Chorion Membrane (dHACM) injection to saline placebo.
Copy to clipboard 
